Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma  被引量:1

在线阅读下载全文

作  者:Kylie E Zane Paul B Nagib Sajid Jalil Khalid Mumtaz Mina S Makary 

机构地区:[1]College of Medicine,The Ohio State University,Columbus,OH 43210,United States [2]Division of Gastroenterology,Hepatology and Nutrition,Department of Internal Medicine,The Ohio State University Wexner Medical Center,Columbus,OH 43210,United States [3]Division of Vascular and Interventional Radiology,Department of Radiology,The Ohio State University Wexner Medical Center,Columbus,OH 43210,United States

出  处:《World Journal of Hepatology》2022年第5期885-895,共11页世界肝病学杂志(英文版)(电子版)

摘  要:Hepatocellular carcinoma(HCC)is the most common cause of liver malignancy and the fourth leading cause of cancer deaths universally.Cure can be achieved for early stage HCC,which is defined as 3 or fewer lesions less than or equal to 3 cm in the setting of Child-Pugh A or B and an ECOG of 0.Patients outside of these criteria who can be down-staged with loco-regional therapies to resection or liver transplantation(LT)also achieve curative outcomes.Traditionally,surgical resection,LT,and ablation are considered curative therapies for early HCC.However,results from recently conducted LEGACY study and DOSISPHERE trial demonstrate that transarterial radio-embolization has curative outcomes for early HCC,leading to its recent incorporation into the Barcelona clinic liver criteria guidelines for early HCC.This review is based on current evidence for curativeintent loco-regional therapies including radioembolization for early-stage HCC.

关 键 词:Hepatocellular carcinoma Loco-regional therapy Radiation segmentectomy Transarterial radio-embolization Ablation Transarterial chemo-embolization Curative intent 

分 类 号:R735.7[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象